Abstract
Background
Repeat liver resection (RLR) for recurrent HCC (rHCC) is a widely accepted treatment modality. However, early recurrence rate is high, frequently resulting in futile resection. We performed this study to evaluate preoperative factors, including the value of inflammatory indices, in predicting early (<1 year) recurrence in patients who underwent RLR for rHCC. This may help clinicians better select patients for RLR, while excluding cases in which RLR for rHCC would likely be futile.
Methods
This is a retrospective study of 80 patients where 90 operative cases of RLR and 84 cases of early recurrence (<1 year) post-RLR were evaluated. Preoperative predictors of early recurrence and overall survival (OS) were assessed.
Results
There were 31 (34.4%) early recurrences with a 5-year OS of 38.9%. Elevated platelet-to-lymphocyte ratio (PLR) >103.6 was a significant independent preoperative predictor of both early recurrence, relative risk (RR) 4.284 (P = 0.001) and OS, RR 2.139 (P = 0.027), while alphafetoprotein (AFP) ≥ 200 was a significant independent preoperative predictor of early recurrence only, RR 11.655 (P = 0.030). Patients were followed-up at a median of 14.3 months with 54.8% develo** intrahepatic recurrences and 19.4% develo** extrahepatic recurrences.
Conclusion
Both, elevated PLR and AFP ≥ 200 were independent predictors of early (<1 year) recurrence after RLR for rHCC, while only an elevated PLR was an independent preoperative prognosticators of overall survival. Indication for RLR should be carefully discussed in patients with relapsed HCC with an elevated PLR, due to the potential of early recurrence and poor overall survival.
Similar content being viewed by others
References
Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3):373
Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38(2):200–207
Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214(2):114
Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC et al (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51(5):890–897
Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP et al (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32(8):1757–1762. https://doi.org/10.1007/s00268-008-9552-6
Mano Y, Shirabe K, Yamashita YI, Harimoto N, Tsujita E, Takeishi K et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301–305
Goh BK, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P et al (2016) Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥ 10 cm) hepatocellular carcinoma. J Surg Oncol 113(6):621–627
Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB et al (2015) Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol 22(13):4138–3148
Yang HJ, Jiang JH, Liu QA, Zhou CM, Du YF, Wu T et al (2017) Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Tumor Biol 39(6):1–8. https://doi.org/10.1177/1010428317707375
Bismuth H (1982) Surgical anatomy and anatomical surgery of the liver. World J Surg 6(1):3–9. https://doi.org/10.1007/BF01656368
Guo YX, Tan EK, Krishnamoorthy TL, Tan CK, Tan BH, Tan TT, et al (2019) Outcome of salvage liver transplant for recurrent hepatocellular carcinoma: a comparison with primary liver transplant. Ann Hepato Biliary Pancreat Surg 23(1):1–7
Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P et al (2003) Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 9(5):513–520
Lee KK, Kim DG, Moon IS, Lee MD, Park JH (2010) Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 101(1):47–53
Goh BK, Teo JY, Chan CY, Lee SY, Cheow PC, Chung AY (2017) Laparoscopic repeat liver resection for recurrent hepatocellular carcinoma. ANZ J Surg 87(10):143–146
Minagawa M, Makuuchi M, Takayama T, Kokudo N (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238(5):703–710
Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, Tashiro H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141(5):589–597
Goh BK, Syn N, Teo JY, Guo YX, Lee SY, Cheow PC et al (2018) Perioperative outcomes of laparoscopic repeat liver resection for recurrent HCC: comparison with open repeat liver resection for recurrent HCC and laparoscopic resection for primary HCC. World J Surg 43:1–8. https://doi.org/10.1007/s00268-018-4828-y
Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT (2008) Biology of hepatocellular carcinoma. Ann Surg Oncol 15(4):962–971
Yamamoto K, Imamura H, Matsuyama Y, Kume Y, Ikeda H, Norman GL et al (2010) AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 45(12):1272–1282
Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P et al (2001) Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34(4):570–575
Huang ZY, Liang BY, **ong M, Zhan DQ, Wei S, Wang GP et al (2012) Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol 19(8):2515–2525
Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227(1):80
Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J et al (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8(1):55
Honn KV, Tang DG, Crissman JD (1992) Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11(3):325–351
Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357(9255):539–545
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860
Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang C et al (2017) Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 8(14):22854
Li X, Chen ZH, **ng YF, Wang TT, Wu DH, Wen JY et al (2015) Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biol 36(4):2263–2269
Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J (2015) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS ONE 10(3):1–14
Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei B et al (2014) Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol 7(2):248–255
Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL et al (2016) A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). BMC Cancer 16(1):137
Yamamura K, Sugimoto H, Kanda M, Yamada S, Nomoto S, Nakayama G et al (2014) Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepato Biliary Pancreat Sci 21(9):682–688
Zhu WJ, Huang CY, Li C, Peng W, Wen TF, Yan LN et al (2013) Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting Milan criteria after curative resection. Asian Pac J Cancer Prev 14(12):7101–7106
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, et al (2015) Prognostic value of the modified Glasgow prognostic score in patients undergoing radical surgery for hepatocellular carcinoma. Medicine 94(36):1–8
Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K (2015) Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg 39(6):1501–1509. https://doi.org/10.1007/s00268-015-2982-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest and declarations
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guo, Y., Chua, D.W., Koh, YX. et al. Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma. World J Surg 43, 2587–2594 (2019). https://doi.org/10.1007/s00268-019-05051-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-05051-6